Abstract
Introduction: VaxigripTetra (TM) (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals &g......
小提示:本篇文献需要登录阅读全文,点击跳转登录